This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

UK Validation of the Automated "AcceXible" Speech Analysis Software

Sponsored by Accexible

About this trial

Last updated 3 years ago

Study ID

AcceXible-Healthy,MCI,Dementia

Status

Unknown status

Type

Observational

Placebo

No

Accepting

18-75 Years
55 to 90 Years
All
All

Trial Timing

Ended 2 years ago

What is this trial about?

Dementia, especially dementia caused by Alzheimer's disease, is considered one of the most severe health problems of our time. It is currently known that the disease begins many years before clinical symptoms appear. The sooner the patient is diagnosed, the sooner the patient will be in a position to prevent further deterioration. A recent orientation is the analysis of language in relation to the description of images with a high and varied semantic and emotional content. It can be studied that changes in the description of an image check if these changes are associated with the evolution of a person with probable impairment both in memory and cognitive as well as emotional, psychiatric, behavioral and even in their interaction with environmental factors especially those associated with socialization and loneliness. The present study has the objective of validating a digital method for detection and follow-up of patients with mild cognitive impairment (MCI) or dementia in a memory clinic setting.

What are the Participation Requirements?

Inclusion Criteria for patients:

- Adult patients 55+ years of age with suspected MCI or diagnosis of dementia referred
into secondary care memory clinic by their General Practitioner.

- Have English as first language (able to speak and understand verbal messages).

- Patients must have agreed to participate in the study and have voluntarily signed
the informed consent.

Inclusion Criteria for healthy volunteers:

- Healthy older adults (55+ years of age), without a diagnosis neurological, or
psychiatric disorders or any clinical evidence of cognitive decline.

- Have English as first language (able to speak and understand verbal messages).

- Controls must have agreed to participate in the study and have voluntarily signed
the informed consent.

Exclusion Criteria for patients:

- To have received a diagnosis of a significant psychiatric disorder or other
cognitive impairment not due to neurodegeneration.

- To have significant vision problems that would affect the ability to perceive visual
stimuli.

- To have significant hearing problems that would affect the ability to understand
verbal cues.

- To be unable to give informed consent to participate in the study.

Exclusion Criteria for healthy volunteers:

- Objective evidence of significant cognitive decline in any one domain.

- Score of <88 on ACE-III cognitive testing.

Locations

Location

Status

Recruiting